Literature DB >> 11219975

Patient selection for oral chemotherapy.

S Sharma1.   

Abstract

Oral chemotherapy has evolved with several new agents such as capecitabine and UFT in active clinical trials or already approved for use in the western world. Several distinct issues, apart from the usual criteria for selecting patients for intravenous chemotherapy, dictate patient selection for these drugs. This article discusses these issues, which include patient preference, selection, and compliance.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11219975

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


  7 in total

1.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment in Turkey.

Authors:  Sultan Kav; Humeyra Bostanci
Journal:  Support Care Cancer       Date:  2006-06-07       Impact factor: 3.603

2.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

Review 3.  Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.

Authors:  Frederik E Stuurman; Bastiaan Nuijen; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

Review 4.  Oral anticancer drugs in the elderly: an overview.

Authors:  Sara Lonardi; Alberto Bortolami; Micaela Stefani; Silvio Monfardini
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

5.  A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer.

Authors:  Yunpeng Yang; Jianhua Chang; Cheng Huang; Yiping Zhang; Jie Wang; Yongqian Shu; Jean Philippe Burillon; Marcello Riggi; Aurélie Petain; Pierre Ferre; Ying Liang; Li Zhang
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

6.  Acceptance of oral chemotherapy in breast cancer patients - a survey study.

Authors:  Sarah Schott; Andreas Schneeweiss; Judith Reinhardt; Thomas Bruckner; Christoph Domschke; Christof Sohn; Michael H Eichbaum
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

7.  Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.

Authors:  Khalid O Alfarouk; Christian-Martin Stock; Sophie Taylor; Megan Walsh; Abdel Khalig Muddathir; Daniel Verduzco; Adil H H Bashir; Osama Y Mohammed; Gamal O Elhassan; Salvador Harguindey; Stephan J Reshkin; Muntaser E Ibrahim; Cyril Rauch
Journal:  Cancer Cell Int       Date:  2015-07-15       Impact factor: 5.722
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.